Novo Nordisk launches Wegovy for obese patients in UK

Novo Nordisk has launched Wegovy (semaglutide injection) as an adjunctive treatment for obese patients in the UK. 

The latest move is aimed at sharing the government’s objective to make obesity care accessible to patients with high unmet medical need.